PLATINUM INVESTMENT MANAGEMENT LTD - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$3,125,727
-35.2%
3,189,517
-8.1%
0.12%
-26.9%
Q2 2023$4,822,791
+17.5%
3,469,634
+34.5%
0.17%
+17.6%
Q1 2023$4,103,114
-53.9%
2,580,575
+80.5%
0.14%
-58.2%
Q4 2022$8,908,906
-7.0%
1,430,0010.0%0.34%
-15.0%
Q3 2022$9,581,000
-7.2%
1,430,001
-11.9%
0.40%
+2.6%
Q2 2022$10,325,000
-18.0%
1,623,440
-40.2%
0.39%
+1.0%
Q1 2022$12,589,000
-7.2%
2,713,1760.0%0.39%
+2.1%
Q4 2021$13,566,000
-34.3%
2,713,176
+58.4%
0.38%
-34.9%
Q3 2021$20,644,000
-43.0%
1,713,1760.0%0.58%
-30.7%
Q2 2021$36,234,000
-19.3%
1,713,176
+7.0%
0.84%
-16.4%
Q1 2021$44,897,000
+10.5%
1,600,613
+2.4%
1.00%
+7.3%
Q4 2020$40,635,000
+26.1%
1,562,869
+80.3%
0.93%
+17.2%
Q3 2020$32,215,000
-26.3%
866,681
+1.8%
0.80%
-20.1%
Q2 2020$43,688,000
+70.7%
851,453
+4.9%
1.00%
+54.3%
Q1 2020$25,593,000
+1016.1%
811,692
+2010.8%
0.65%
+1335.6%
Q4 2019$2,293,00038,4540.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 2,629,835$116,685,00025.08%
Aviva Holdings Ltd. 1,200,100$53,248,00014.21%
Boxer Capital, LLC 1,375,000$61,009,0006.77%
BB BIOTECH AG 3,282,964$145,665,0003.86%
Rhenman & Partners Asset Management AB 353,961$15,705,0001.57%
PFM Health Sciences, LP 1,970,134$87,415,0001.28%
Bellevue Group AG 391,852$17,386,0001.10%
Pentwater Capital Management LP 2,351,500$104,336,0000.88%
Partner Investment Management, L.P. 25,440$1,129,0000.86%
SABBY MANAGEMENT, LLC 100,369$4,453,0000.57%
View complete list of ESPERION THERAPEUTICS INC NE shareholders